Oxford Biomedica Plc

London Exchange

Oxford Biomedica signs deal to acquire of ABL Europe for €15 million
ByAli Mirza December 4, 2023December 4, 2023

OXFORD, UK: Oxford Biomedica plc has entered into a sale and purchase agreement with TSGH SAS, a subsidiary of Institut Mérieux SA, for the acquisition of ABL Europe SAS. Acquisition of ABL Europe by Oxford Biomedica for a consideration of…

Read More Oxford Biomedica signs deal to acquire of ABL Europe for €15 million
Companies listed on London Stock Exchange

Oxford Biomedica Plc (LSE:OXB)
ByNNR April 6, 2021June 6, 2024

Oxford Biomedica Plc (LSE:OXB) is a leading, fully integrated, gene and cell therapy group focused on developing life changing treatments for serious diseases. Oxford Biomedica Plc (LSE:OXB) and its subsidiaries (the “Group”) have built a sector leading lentiviral vector delivery…

Read More Oxford Biomedica Plc (LSE:OXB)